Ranolazine — Discount Pricing

Other medications in Heart & Cardiovascular

• Riociguat
• Rivaroxaban
• Rosuvastatin
• Sacubitril-Valsartan
• Selexipag
• Sildenafil (PAH)
• Simvastatin
• Sotalol

About Ranolazine

Living with chronic angina can be challenging, but managing it shouldn't break the bank. Ranolazine is a key medication for persistent chest pain, and with TheDrugClub, accessing it is simpler and more affordable than ever. Discover how our members receive this vital treatment with a $0 co-pay and the convenience of free home delivery.

Understanding Ranolazine: A Lifeline for Chronic Angina

Ranolazine is a prescription medication primarily used to treat chronic angina, a type of chest pain caused by reduced blood flow to the heart. It's often prescribed when other angina medications haven't been fully effective or aren't tolerated well. It helps reduce the frequency of angina attacks and improve exercise tolerance, allowing individuals to lead more active lives. It's important to note that ranolazine is not used to treat acute angina attacks, but rather as a long-term management solution for persistent symptoms.

How Ranolazine Works to Ease Chest Pain

Unlike some other angina medications that primarily affect heart rate or blood pressure, ranolazine works through a unique mechanism. It specifically inhibits a late sodium current in heart muscle cells. By doing so, it helps to prevent an overload of calcium within these cells, which can otherwise contribute to the heart's inability to relax properly and receive adequate blood supply. This improved cellular function allows the heart to work more efficiently, reducing the oxygen demand and increasing blood flow, thereby lessening angina symptoms. It's a targeted approach that helps the heart function better at a cellular level.

The Cost of Chronic Angina Treatment

For many, the cost of prescription medications like ranolazine can be a significant barrier to consistent treatment. Without insurance, or with high deductibles and co-pays, the monthly cost for ranolazine (often prescribed under the brand name Ranexa) can range from several hundred to over a thousand dollars. Even generic versions, while generally less expensive, can still represent a substantial financial burden. These high costs can lead patients to skip doses or abandon treatment altogether, compromising their health and quality of life.

TheDrugClub: Your Solution for Affordable Ranolazine

At TheDrugClub, we believe that managing chronic conditions like angina should be accessible and stress-free. That's why we've revolutionized how our members access essential medications, including ranolazine. As a member, you can receive your ranolazine prescription with a $0 co-pay, eliminating the financial strain often associated with this vital medication.

Our unique membership model allows us

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Ranolazine is approved for (FDA label)

Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine is an antianginal indicated for the treatment of chronic angina. (1)

Source: Read the full FDA label on DailyMed. Label effective date: August 19, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Ranolazine (FDA label)

Ranolazine extended-release tablets are supplied as film-coated, oval-shaped, extended-release tablets in the following strengths: 500 mg tablets are orange colored, with RZ1 on one side and plain on other side 1000 mg tablets are yellow colored, with RZ2 on one side and plain on other side Extended-release tablets: 500 mg, 1000 mg (3)

Source: FDA prescribing information (DailyMed). Set ID: 90c5a0c2-542c-467e-9c0c-ef320534c560. SPL document ID: 596834c7-18f1-07a0-e063-6294a90a9df6. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Ranolazine (FDA label)

Most common adverse reactions (greater than 4% and more common than with placebo) are dizziness, headache, constipation, nausea. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Ajanta Pharma USA, Inc., at 1-855-664-7744 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. A total of 2018 patients with chronic angina were treated with ranolazine in controlled clinical trials.

Source: FDA prescribing information (DailyMed). Set ID: 90c5a0c2-542c-467e-9c0c-ef320534c560. SPL document ID: 596834c7-18f1-07a0-e063-6294a90a9df6. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Ranolazine (FDA label)

Ranolazine extended-release tablets are contraindicated in patients: Taking strong inhibitors of CYP3A [see Drug Interactions (7.1) ] Taking inducers of CYP3A [see Drug Interactions (7.1) ] With liver cirrhosis [see Use in Specific Populations (8.6) ] Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin, nelfinavir) (4 , 7.1) CYP3A inducers (e.g., rifampin, phenobarbital, St. John’s wort) (4 , 7.1) Liver cirrhosis (4 , 8.6)

Source: FDA prescribing information (DailyMed). Set ID: 90c5a0c2-542c-467e-9c0c-ef320534c560. SPL document ID: 596834c7-18f1-07a0-e063-6294a90a9df6. Label effective date: August 19, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.